共 50 条
- [1] Influence of repeated doses of ketoconazole, a potent CYP 3A4 inhibitor, on the pharmacokinetic profile of eplivanserin, a new sleep agent, in healthy male subjectsSLEEP, 2008, 31 : A40 - A40Zannad, F.Saubadu, S.Martinez, J. M.Brunet, A.
- [2] Evaluation of the interaction of pantoprazole on the pharmacokinetic profile of the novel sleep compound eplivanserin in healthy male subjectsJOURNAL OF SLEEP RESEARCH, 2008, 17 : 207 - 208Krupka, E.Brunet, A.Saubadu, S.
- [3] Evaluation of the interaction of repeated doses of the strong CYP3A4 inhibitor ketoconazole on the pharmacokinetic profile of the novel sleep compound.. eplivanserin, in healthy male subjectsJOURNAL OF SLEEP RESEARCH, 2008, 17 : 208 - 209Zannad, F.Brunet, A.Saubadu, S.Pinquier, J. L.
- [4] Repeated doses of eplivanserin, a new sleep agent, do not alter the pharmacokinetics of an oral contraceptive in healthy womenSLEEP, 2008, 31 : A39 - A40Caplain, H.Cattelin, F.Brunet, A.
- [5] Effect of repeated doses of the novel sleep compound eplivanserin on cardiac ventricular repolarisation in healthy subjectsJOURNAL OF SLEEP RESEARCH, 2008, 17 : 207 - 207Saubadu, S.Homery, M.Delfolie, A.Brunet, A.Pinquier, J.
- [6] Effect of two dose regimens of eplivanserin, a new sleep agent, on sleep and psychomotor performance of healthy subjectsSLEEP, 2008, 31 : A33 - A33Hindmarch, ICattelin, F.
- [7] Evaluation of potential food effect on pharmacokinetic parameters of a single dose of 5 mg eplivanserin, a new sleep agent, administered orally to healthy subjectsSLEEP, 2008, 31 : A39 - A39Nougarede, M. D.Clot, P. F.Brunet, A.
- [8] A phase I study of the effect of repeated oral doses of pantoprazole on the pharmacokinetics of a single dose of fedratinib in healthy male subjectsCancer Chemotherapy and Pharmacology, 2020, 85 : 995 - 1001Ken OgasawaraBradley VinceChristine XuMeng ZhangMaria PalmisanoGopal Krishna
- [9] A phase I study of the effect of repeated oral doses of pantoprazole on the pharmacokinetics of a single dose of fedratinib in healthy male subjectsCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (05) : 995 - 1001Ogasawara, KenVince, BradleyXu, ChristineZhang, MengPalmisano, MariaKrishna, Gopal
- [10] The pharmacokinetics of an oral contraceptive were not affected by repeated doses of the novel sleep compound eplivanserin in healthy womenJOURNAL OF SLEEP RESEARCH, 2008, 17 : 208 - 208Caplain, H. R.Saubadu, S.Brunet, A.